Packaged Foods
Compare Stocks
5 / 10Stock Comparison
NOMD vs MKC vs SJM vs CAG vs CPB
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
Packaged Foods
Packaged Foods
Packaged Foods
NOMD vs MKC vs SJM vs CAG vs CPB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Packaged Foods | Packaged Foods | Packaged Foods | Packaged Foods | Packaged Foods |
| Market Cap | $1.44B | $12.14B | $10.58B | $6.86B | $6.34B |
| Revenue (TTM) | $3.03B | $6.84B | $8.93B | $11.18B | $10.04B |
| Net Income (TTM) | $137M | $789M | $-1.26B | $13M | $550M |
| Gross Margin | 27.1% | 37.9% | 33.6% | 24.6% | 29.3% |
| Operating Margin | 10.7% | 15.7% | -8.0% | 13.1% | 12.1% |
| Forward P/E | 6.9x | 15.5x | 11.0x | 8.4x | 9.7x |
| Total Debt | $2.29B | $4.00B | $7.76B | $8.31B | $7.21B |
| Cash & Equiv. | $325M | $96M | $70M | $68M | $132M |
NOMD vs MKC vs SJM vs CAG vs CPB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nomad Foods Limited (NOMD) | 100 | 47.8 | -52.2% |
| McCormick & Company… (MKC) | 100 | 54.7 | -45.3% |
| The J. M. Smucker C… (SJM) | 100 | 87.3 | -12.7% |
| Conagra Brands, Inc. (CAG) | 100 | 41.2 | -58.8% |
| Campbell Soup Compa… (CPB) | 100 | 41.7 | -58.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NOMD vs MKC vs SJM vs CAG vs CPB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NOMD ranks third and is worth considering specifically for value.
- Lower P/E (6.9x vs 9.7x)
MKC is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 26.9% 10Y total return vs SJM's 5.6%
- 11.5% margin vs SJM's -14.1%
- 6.0% ROA vs SJM's -7.7%, ROIC 8.5% vs -3.4%
SJM carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.04, current ratio 0.81x
- Beta 0.04, yield 4.3%, current ratio 0.81x
- 6.7% revenue growth vs CAG's -4.8%
- Beta 0.04 vs NOMD's 0.07
CAG is the clearest fit if your priority is income & stability and valuation efficiency.
- Dividend streak 6 yrs, beta 0.06, yield 9.8%
- PEG 1.21 vs MKC's 14.63
- 9.8% yield, 6-year raise streak, vs MKC's 3.7%
CPB is the clearest fit if your priority is growth exposure.
- Rev growth 6.4%, EPS growth 6.3%, 3Y rev CAGR 6.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.7% revenue growth vs CAG's -4.8% | |
| Value | Lower P/E (6.9x vs 9.7x) | |
| Quality / Margins | 11.5% margin vs SJM's -14.1% | |
| Stability / Safety | Beta 0.04 vs NOMD's 0.07 | |
| Dividends | 9.8% yield, 6-year raise streak, vs MKC's 3.7% | |
| Momentum (1Y) | -7.5% vs NOMD's -43.5% | |
| Efficiency (ROA) | 6.0% ROA vs SJM's -7.7%, ROIC 8.5% vs -3.4% |
NOMD vs MKC vs SJM vs CAG vs CPB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NOMD vs MKC vs SJM vs CAG vs CPB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MKC leads in 1 of 6 categories
NOMD leads 1 • CPB leads 1 • SJM leads 1 • CAG leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MKC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CAG is the larger business by revenue, generating $11.2B annually — 3.7x NOMD's $3.0B. MKC is the more profitable business, keeping 11.5% of every revenue dollar as net income compared to SJM's -14.1%. On growth, SJM holds the edge at +7.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.0B | $6.8B | $8.9B | $11.2B | $10.0B |
| EBITDAEarnings before interest/tax | $435M | $1.3B | -$595M | $1.9B | $1.6B |
| Net IncomeAfter-tax profit | $137M | $789M | -$1.3B | $13M | $550M |
| Free Cash FlowCash after capex | $252M | $879M | $971M | $634M | $919M |
| Gross MarginGross profit ÷ Revenue | +27.1% | +37.9% | +33.6% | +24.6% | +29.3% |
| Operating MarginEBIT ÷ Revenue | +10.7% | +15.7% | -8.0% | +13.1% | +12.1% |
| Net MarginNet income ÷ Revenue | +4.5% | +11.5% | -14.1% | +0.1% | +5.5% |
| FCF MarginFCF ÷ Revenue | +8.3% | +12.8% | +10.9% | +5.7% | +9.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.6% | +2.9% | +7.0% | -6.8% | -4.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -123.1% | +5.0% | -9.3% | -3.4% | -17.2% |
Valuation Metrics
NOMD leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 6.0x trailing earnings, CAG trades at a 64% valuation discount to MKC's 16.3x P/E. Adjusting for growth (PEG ratio), CAG offers better value at 0.85x vs MKC's 15.47x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $1.4B | $12.1B | $10.6B | $6.9B | $6.3B |
| Enterprise ValueMkt cap + debt − cash | $3.7B | $16.0B | $18.3B | $15.1B | $13.4B |
| Trailing P/EPrice ÷ TTM EPS | 9.46x | 16.35x | -8.59x | 5.95x | 10.57x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.86x | 15.46x | 11.01x | 8.44x | 9.74x |
| PEG RatioP/E ÷ EPS growth rate | — | 15.47x | — | 0.85x | — |
| EV / EBITDAEnterprise value multiple | 7.34x | 12.12x | — | 8.61x | 7.51x |
| Price / SalesMarket cap ÷ Revenue | 0.40x | 1.78x | 1.21x | 0.59x | 0.62x |
| Price / BookPrice ÷ Book value/share | 0.52x | 2.24x | 1.74x | 0.77x | 1.63x |
| Price / FCFMarket cap ÷ FCF | 4.85x | 16.40x | 12.96x | 5.27x | 8.99x |
Profitability & Efficiency
CPB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CPB delivers a 14.0% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-24 for SJM. MKC carries lower financial leverage with a 0.69x debt-to-equity ratio, signaling a more conservative balance sheet compared to CPB's 1.85x. On the Piotroski fundamental quality scale (0–9), CPB scores 7/9 vs NOMD's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.3% | +13.7% | -24.0% | +0.2% | +14.0% |
| ROA (TTM)Return on assets | +2.2% | +6.0% | -7.7% | +0.1% | +3.7% |
| ROICReturn on invested capital | +5.5% | +8.5% | -3.4% | +6.0% | +9.1% |
| ROCEReturn on capital employed | +6.2% | +10.7% | -4.3% | +8.2% | +11.4% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 0.92x | 0.69x | 1.28x | 0.93x | 1.85x |
| Net DebtTotal debt minus cash | $2.0B | $3.9B | $7.7B | $8.2B | $7.1B |
| Cash & Equiv.Liquid assets | $325M | $96M | $70M | $68M | $132M |
| Total DebtShort + long-term debt | $2.3B | $4.0B | $7.8B | $8.3B | $7.2B |
| Interest CoverageEBIT ÷ Interest expense | 2.52x | 5.65x | -1.88x | 1.56x | 3.14x |
Total Returns (Dividends Reinvested)
SJM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SJM five years ago would be worth $8,802 today (with dividends reinvested), compared to $4,026 for NOMD. Over the past 12 months, SJM leads with a -7.5% total return vs NOMD's -43.5%. The 3-year compound annual growth rate (CAGR) favors SJM at -10.6% vs CPB's -22.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -15.4% | -28.1% | +4.0% | -13.0% | -20.5% |
| 1-Year ReturnPast 12 months | -43.5% | -33.6% | -7.5% | -31.5% | -35.4% |
| 3-Year ReturnCumulative with dividends | -40.3% | -39.8% | -28.5% | -50.8% | -52.6% |
| 5-Year ReturnCumulative with dividends | -59.7% | -37.2% | -12.0% | -44.3% | -41.9% |
| 10-Year ReturnCumulative with dividends | +40.1% | +26.9% | +5.6% | -27.9% | -44.9% |
| CAGR (3Y)Annualised 3-year return | -15.8% | -15.6% | -10.6% | -21.1% | -22.0% |
Risk & Volatility
Evenly matched — MKC and SJM each lead in 1 of 2 comparable metrics.
Risk & Volatility
MKC is the less volatile stock with a -0.03 beta — it tends to amplify market swings less than NOMD's 0.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SJM currently trades 83.3% from its 52-week high vs NOMD's 51.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.07x | -0.03x | 0.04x | 0.06x | -0.02x |
| 52-Week HighHighest price in past year | $19.71 | $78.16 | $119.39 | $23.47 | $36.16 |
| 52-Week LowLowest price in past year | $9.17 | $47.31 | $88.25 | $13.61 | $19.76 |
| % of 52W HighCurrent price vs 52-week peak | +51.3% | +61.3% | +83.3% | +61.1% | +58.8% |
| RSI (14)Momentum oscillator 0–100 | 58.6 | 33.8 | 50.1 | 36.1 | 46.7 |
| Avg Volume (50D)Average daily shares traded | 1.6M | 4.0M | 2.1M | 14.1M | 9.1M |
Analyst Outlook
Evenly matched — MKC and CAG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NOMD as "Buy", MKC as "Hold", SJM as "Hold", CAG as "Hold", CPB as "Hold". Consensus price targets imply 52.8% upside for MKC (target: $73) vs 14.0% for SJM (target: $113). For income investors, CAG offers the higher dividend yield at 9.75% vs MKC's 3.74%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $13.50 | $73.20 | $113.38 | $17.55 | $25.83 |
| # AnalystsCovering analysts | 13 | 30 | 29 | 25 | 29 |
| Dividend YieldAnnual dividend ÷ price | +7.1% | +3.7% | +4.3% | +9.8% | +7.2% |
| Dividend StreakConsecutive years of raises | 2 | 27 | 15 | 6 | 1 |
| Dividend / ShareAnnual DPS | $0.61 | $1.79 | $4.28 | $1.40 | $1.53 |
| Buyback YieldShare repurchases ÷ mkt cap | +16.5% | +0.3% | +0.0% | +0.9% | +1.0% |
MKC leads in 1 of 6 categories (Income & Cash Flow). NOMD leads in 1 (Valuation Metrics). 2 tied.
NOMD vs MKC vs SJM vs CAG vs CPB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NOMD or MKC or SJM or CAG or CPB a better buy right now?
For growth investors, The J.
M. Smucker Company (SJM) is the stronger pick with 6. 7% revenue growth year-over-year, versus -2. 2% for Nomad Foods Limited (NOMD). Conagra Brands, Inc. (CAG) offers the better valuation at 6. 0x trailing P/E (8. 4x forward), making it the more compelling value choice. Analysts rate Nomad Foods Limited (NOMD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NOMD or MKC or SJM or CAG or CPB?
On trailing P/E, Conagra Brands, Inc.
(CAG) is the cheapest at 6. 0x versus McCormick & Company, Incorporated at 16. 3x. On forward P/E, Nomad Foods Limited is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Conagra Brands, Inc. wins at 1. 21x versus McCormick & Company, Incorporated's 14. 63x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — NOMD or MKC or SJM or CAG or CPB?
Over the past 5 years, The J.
M. Smucker Company (SJM) delivered a total return of -12. 0%, compared to -59. 7% for Nomad Foods Limited (NOMD). Over 10 years, the gap is even starker: NOMD returned +40. 1% versus CPB's -44. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NOMD or MKC or SJM or CAG or CPB?
By beta (market sensitivity over 5 years), McCormick & Company, Incorporated (MKC) is the lower-risk stock at -0.
03β versus Nomad Foods Limited's 0. 07β — meaning NOMD is approximately -355% more volatile than MKC relative to the S&P 500. On balance sheet safety, McCormick & Company, Incorporated (MKC) carries a lower debt/equity ratio of 69% versus 185% for Campbell Soup Company — giving it more financial flexibility in a downturn.
05Which is growing faster — NOMD or MKC or SJM or CAG or CPB?
By revenue growth (latest reported year), The J.
M. Smucker Company (SJM) is pulling ahead at 6. 7% versus -2. 2% for Nomad Foods Limited (NOMD). On earnings-per-share growth, the picture is similar: Campbell Soup Company grew EPS 6. 3% year-over-year, compared to -262. 3% for The J. M. Smucker Company. Over a 3-year CAGR, CPB leads at 6. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NOMD or MKC or SJM or CAG or CPB?
McCormick & Company, Incorporated (MKC) is the more profitable company, earning 11.
5% net margin versus -14. 1% for The J. M. Smucker Company — meaning it keeps 11. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MKC leads at 16. 0% versus -7. 7% for SJM. At the gross margin level — before operating expenses — SJM leads at 38. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NOMD or MKC or SJM or CAG or CPB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Conagra Brands, Inc. (CAG) is the more undervalued stock at a PEG of 1. 21x versus McCormick & Company, Incorporated's 14. 63x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Nomad Foods Limited (NOMD) trades at 6. 9x forward P/E versus 15. 5x for McCormick & Company, Incorporated — 8. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MKC: 52. 8% to $73. 20.
08Which pays a better dividend — NOMD or MKC or SJM or CAG or CPB?
All stocks in this comparison pay dividends.
Conagra Brands, Inc. (CAG) offers the highest yield at 9. 8%, versus 3. 7% for McCormick & Company, Incorporated (MKC).
09Is NOMD or MKC or SJM or CAG or CPB better for a retirement portfolio?
For long-horizon retirement investors, McCormick & Company, Incorporated (MKC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
03), 3. 7% yield). Both have compounded well over 10 years (MKC: +26. 9%, CAG: -27. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NOMD and MKC and SJM and CAG and CPB?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NOMD is a small-cap deep-value stock; MKC is a mid-cap deep-value stock; SJM is a mid-cap income-oriented stock; CAG is a small-cap deep-value stock; CPB is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.